IAVI receives up to $99 million US contract for Ebola vaccine developmentBiomedical research organization IAVI was awarded $36 million under a US government contract worth up to $99 million to advance development of its single-dose Ebola vaccine.Oct 28, 2026·2 sourcesEbola outbreak in the Democratic Republic of the Congo 2026Biotech innovationEbola outbreakVaccine developmentInfectious Disease and OutbreaksEpidemic preparedness00
